|
|
Volumn 25, Issue 12, 2011, Pages 1389-1394
|
|
Quantification of lurasidone, an atypical antipsychotic drug, in rat plasma with high-performance liquid chromatography with tandem mass spectrometry
a
|
|
Author keywords
LC MS MS; Lurasidone; Pharmacokinetics
|
|
Indexed keywords
BODY FLUIDS;
ELECTROSPRAY IONIZATION;
FORMIC ACID;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
MASS SPECTROMETRY;
PHARMACOKINETICS;
RATS;
ANTIPSYCHOTIC DRUG;
ATYPICAL ANTIPSYCHOTICS;
HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY;
LC-MS-MS;
LC.MS/MS;
LIQUID CHROMATOGRAPHY WITH TANDEM MASS SPECTROMETRY (LCMS/MS);
LURASIDONE;
PLASMA SAMPLES;
RAT PLASMA;
TANDEM MASS SPECTROMETRIC;
ACETONITRILE;
ACETONITRILE;
ATYPICAL ANTIPSYCHOTIC AGENT;
FORMIC ACID;
LURASIDONE;
ZIPRASIDONE;
ACCURACY;
ANALYTIC METHOD;
ANIMAL EXPERIMENT;
AREA UNDER THE CURVE;
ARTICLE;
CENTRIFUGATION;
DISTRIBUTION VOLUME;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG DETERMINATION;
DRUG HALF LIFE;
DRUG ISOLATION;
DRUG STABILITY;
ELECTROSPRAY MASS SPECTROMETRY;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
MALE;
MAXIMUM PLASMA CONCENTRATION;
NONHUMAN;
QUANTITATIVE ASSAY;
RAT;
REPRODUCIBILITY;
SENSITIVITY AND SPECIFICITY;
SINGLE DRUG DOSE;
STANDARD;
SUPERNATANT;
TANDEM MASS SPECTROMETRY;
TIME TO MAXIMUM PLASMA CONCENTRATION;
RATTUS;
|
|
EID: 80055096909
PISSN: 02693879
EISSN: 10990801
Source Type: Journal
DOI: 10.1002/bmc.1625 Document Type: Article |
|
Times cited : (33)
|
|
References (7)
|
